Journal of Hematology & Thromboembolic Diseases : Citations & Metrics Report
Articles published in Journal of Hematology & Thromboembolic Diseases have been cited by esteemed scholars and scientists all around the world. Journal of Hematology & Thromboembolic Diseases has got h-index 16, which means every article in Journal of Hematology & Thromboembolic Diseases has got 16 average citations.
Following are the list of articles that have cited the articles published in Journal of Hematology & Thromboembolic Diseases.
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
Year wise published articles |
62 | 50 | 23 | 6 | 15 |
Year wise citations received |
136 | 146 | 135 | 123 | 106 |
| Journal total citations count | 1065 |
| Journal impact factor | 2.67 |
| Journal 5 years impact factor | 4.32 |
| Journal cite score | 4.94 |
| Journal h-index | 16 |
| Journal h-index since 2018 | 12 |
Important citations (901)
Norton, a., pan, c., iskenderian, a., & strack-logue, b. (2020). |
|
Rosado-quiñones, a. m., & zaragoza-urdaz, r. (2019). hereditary angioedema: an updated experience with patients with angioedema in puerto rico. puerto rico health sciences journal, 38(4). |
|
Tarandovskiy, i., buehler, p., & karnaukhova, e. (2017). supra-physiological concentrations of c1 esterase inhibitor enhance thrombin generation in the presence of thrombomodulin. |
|
Primary large b-cell mediastinal lymphoma: treatment |
|
Relapsed/refractory primary mediastinal large b-cell lymphoma: a structured review of epidemiology, treatment guidelines and real-world treatment practices |
|
Role of haemoglobin and their diseases |
|
Role of haemoglobin and their diseases |
|
Prodeus, a.p., ustinova, m.v., lekmanov, a.u., kudryashov, n.v., & kudlai, d.a. (2019). c1 esterase inhibitor: approaches to rational pharmacotherapy of neonatal sepsis. pediatriya named after gn speransky , 98 (3). |
|
Tanaka, k. a., mondal, s., morita, y., williams, b., strauss, e. r., & cicardi, m. (2020). perioperative management of patients with hereditary angioedema with special considerations for cardiopulmonary bypass. anesthesia & analgesia, 131(1), 155-169. |
|
Wong, c., muguiro, d. h., lavergne, s., behling-kelly, e., & goggs, r. (2018). pharmacokinetics of human recombinant c1-esterase inhibitor and development of anti-drug antibodies in healthy dogs. veterinary immunology and immunopathology, 203, 66-72. |
|
Karnaukhova, e. (2021). c1-inhibitor: structure, functional diversity and therapeutic development. current medicinal chemistry. |
|
A review on genetic disorders and syndromes |
|
Prodeus, a.p., ustinova, m.v., korsunsky, a.a., & goncharov, a.g. (2018). new aspects of the pathogenesis of sepsis and septic shock in children. the complement system as a target for effective therapy. infection and immunity , 8 (1). |
|
Role of haemoglobin and their diseases |
|
Tarandovskiy, i. d., rajabi, a. a., karnaukhova, e., & buehler, p. w. (2019). contradictory to its effects on thrombin, c1-inhibitor reduces plasmin generation in the presence of thrombomodulin. journal of thrombosis and thrombolysis, 48(1), 81-87. |
|
Tarandovskiy, i. d., buehler, p. w., ataullakhanov, f. i., & karnaukhova, e. (2019). c1-esterase inhibitor enhances thrombin generation and spatial fibrin clot propagation in the presence of thrombomodulin. thrombosis research, 176, 54-60. |
|
Dijk, m., holkers, j., voskamp, p., giannetti, b. m., waterreus, w. j., van veen, h. a., & pannu, n. s. (2016). how dextran sulfate affects c1-inhibitor activity: a model for polysaccharide potentiation. structure, 24(12), 2182-2189. |
|
Genetic biomarkers related to hemarthrosis, inflammation, and cartilage structure in pediatric patients with hemophilic arthropathy |
|
Iborra-egea, o., rueda, f., garcía-garcía, c., borràs, e., sabidó, e., & bayes-genis, a. (2020). molecular signature of cardiogenic shock. european heart journal, 41(39), 3839-3848. |
|
Riedl, m. (2015). recombinant human c1 esterase inhibitor in the management of hereditary angioedema. clinical drug investigation, 35(7), 407-417. |
|